RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells

[1]  D. Hu,et al.  Estrogen Receptor α, Fos-Related Antigen-2, and c-Jun Coordinately Regulate Human UDP Glucuronosyltransferase 2B15 and 2B17 Expression in Response to 17β-Estradiol in MCF-7 Cells , 2009, Molecular Pharmacology.

[2]  Yrjö Collan,et al.  Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors , 2009, BMC Research Notes.

[3]  K. Kimbro,et al.  A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment , 2008, Molecular Biology Reports.

[4]  C. Thomas,et al.  Caveolae structure and function , 2008, Journal of cellular and molecular medicine.

[5]  L. Milanesi,et al.  17Beta-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway. , 2008, The Journal of endocrinology.

[6]  E. Levin,et al.  Extranuclear steroid receptors: nature and actions. , 2007, Endocrine reviews.

[7]  Wan-Cai Yang,et al.  Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. , 2006, The American journal of pathology.

[8]  Rakesh Kumar,et al.  Steroid hormone receptor signaling in tumorigenesis , 2005, Journal of cellular biochemistry.

[9]  M. Lisanti,et al.  Caveolin-1 in oncogenic transformation, cancer, and metastasis. , 2005, American journal of physiology. Cell physiology.

[10]  C. Watson,et al.  Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells , 2004, Breast Cancer Research.

[11]  P. Visca,et al.  Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. , 2005, Molecular biology of the cell.

[12]  P. Jenö,et al.  Caveolae: biochemical analysis , 2004, Molecular Biology Reports.

[13]  W. Zou,et al.  Caveolin-1 haploinsufficiency leads to partial transformation of human breast epithelial cells. , 2003, Anticancer research.

[14]  Sabine Riethdorf,et al.  FosB is Highly Expressed in Normal Mammary Epithelia, but Down-Regulated in Poorly Differentiated Breast Carcinomas , 2003, Breast Cancer Research and Treatment.

[15]  S. Woodman,et al.  Caveolae: From Cell Biology to Animal Physiology , 2002, Pharmacological Reviews.

[16]  S. Shack,et al.  Loss in oxidative stress tolerance with aging linked to reduced extracellular signal‐regulated kinase and Akt kinase activities , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  M. Marino,et al.  β‐estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells , 2001, Journal of cellular physiology.

[18]  M. Lisanti,et al.  Withdrawal of “Caveolae and Their Coat Proteins, the Caveolins: From Electron Microscopic Novelty to Biological Launching Pad” [Journal of Cellular Physiology 186(3) 329‐337 (2001)] , 2001, Journal of cellular physiology.

[19]  E. Wagner,et al.  Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage , 2001, Cell.

[20]  E. Levin,et al.  Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. , 2000, Molecular endocrinology.

[21]  K. Milde-Langosch,et al.  Expression of cell cycle–regulatory proteins Rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: Correlations with expression of activating protein‐1 family members , 2000, International journal of cancer.

[22]  J. Bender,et al.  Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Kitsis,et al.  Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.

[24]  Y. Yarden,et al.  Cyclin D1 Is Required for Transformation by Activated Neu and Is Induced through an E2F-Dependent Signaling Pathway , 2000, Molecular and Cellular Biology.

[25]  J. Swantek,et al.  New insights into the control of MAP kinase pathways. , 1999, Experimental Cell Research.

[26]  Richard J. Lee,et al.  Reciprocal Regulation of Neu Tyrosine Kinase Activity and Caveolin-1 Protein Expression in Vitro and in Vivo , 1998, The Journal of Biological Chemistry.

[27]  J. Engelman,et al.  Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav‐1, ‐2, and ‐3) , 1998, FEBS letters.

[28]  E. Krebs,et al.  Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. , 1997, Endocrinology.

[29]  M. Lisanti,et al.  Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. , 1996, The Journal of biological chemistry.

[30]  C. Arteaga,et al.  Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice. , 1996, Cancer research.

[31]  M. Karin.  The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[32]  G. Cooper,et al.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.

[33]  L. Milanesi,et al.  17b-Estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway , 2008 .

[34]  E. Levin,et al.  ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. , 2002, Molecular endocrinology.

[35]  M. Lisanti,et al.  Caveolae and their coat proteins, the caveolins: from electron microscopic novelty to biological launching pad. , 2001, Journal of cellular physiology.